Sign in
4/A

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-000292

Options or other derivatives

  • Chief Business - Strategy Off acquired 65,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Lin Patrick Chief Business - Strategy Off 2025-01-29 Grant or award · Warrants +43,500 43,500 I
Lin Patrick Chief Business - Strategy Off 2025-01-29 Grant or award · Warrants +21,750 21,750 I
Loading xslF345X05/form4.xml…